Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Dogtopia, the nation's largest and fastest-growing pet wellness franchise, is commemorating a notable year of achievements in 2024. From surpassing 285 open daycare centers to earning accolades from ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...

Recule, a biotechnology company pioneering RNA therapies, and GBI Biomanufacturing, a leading contract development and manufacturing organization (CDMO), today announced a strategic partnership to ...

NEWTOWN SQUARE, PA, USA and SHANGHAI, China I January 21, 2025 I ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development ...

SHANGHAI, China I January 9, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC ...